Breast Cancer HER2 (ERBB2) Status by Next-Generation Sequencing Compared to Traditional Methods

被引：0
|
作者：
Russell, Meaghan K. [1 ]
Pantazi, Angeliki [1 ]
Lyle, Stephen [2 ]
Tse, Julie Y. [3 ]
机构：
[1] KEW Inc, Lethbridge, AB, Canada
[2] Univ Massachusetts, Worcester, MA 01605 USA
[3] KEW Inc, Tufts Med Ctr, Boston, MA USA
来源：
LABORATORY INVESTIGATION | 2018年 / 98卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
291
引用
收藏
页码：103 / 103
页数：1
相关论文
共 50 条
  • [1] Breast Cancer HER2 (ERBB2) Status by Next-Generation Sequencing Compared to Traditional Methods
    Russell, Meaghan K.
    Pantazi, Angeliki
    Lyle, Stephen
    Tse, Julie Y.
    MODERN PATHOLOGY, 2018, 31 : 103 - 103
  • [2] HER2/ERBB2 copy number analysis by targeted next-generation sequencing in breast cancer
    Xia, Daniel
    Kuo, Frank
    Hughes, Melissa
    Lindeman, Neal
    Manning, Danielle
    Files, Janet
    Strauss, Sarah
    Kirkner, Greg
    Mohammed-Abreu, Ayesha
    Winer, Eric
    Tolaney, Sara M.
    Lin, Nancy U.
    Dillon, Deborah A.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2024, 161 (05) : 436 - 442
  • [3] HER2/ERBB2 Testing in Breast Carcinoma by Next Generation Sequencing
    Wong, Adele
    Bhan, Atul
    Lennerz, Jochen K.
    Brachtel, Elena
    MODERN PATHOLOGY, 2017, 30 : 522A - 522A
  • [4] HER2/ERBB2 Testing in Breast Carcinoma by Next Generation Sequencing
    Wong, Adele
    Bhan, Atul
    Lennerz, Jochen K.
    Brachtel, Elena
    LABORATORY INVESTIGATION, 2017, 97 : 522A - 522A
  • [5] Targeted Next-Generation Sequencing Enables Reliable Detection of HER2 (ERBB2) Status in Breast Cancer and Provides Ancillary Information of Clinical Relevance
    Pfarr, Nicole
    Penzel, Roland
    Endris, Volker
    Lier, Clemens
    Flechtenmacher, Christa
    Volckmar, Anna-Lena
    Kirchner, Martina
    Budczies, Jan
    Leichsenring, Jonas
    Herpel, Esther
    Noske, Aurelia
    Weichert, Wilko
    Schneeweiss, Andreas
    Schirmacher, Peter
    Sinn, Hans-Peter
    Stenzinger, Albrecht
    GENES CHROMOSOMES & CANCER, 2017, 56 (04): : 255 - 265
  • [6] Defining ERBB2 amplification status by Next-Generation Sequencing
    Nakamura, Kohei
    Aimono, Eriko
    Oba, Junna
    Ueki, Arisa
    Imai, Mitsuho
    Yanagita, Emmy
    Yamada, Hiroshi
    Hayashi, Hideyuki
    Nishihara, Hiroshi
    CANCER SCIENCE, 2021, 112 : 320 - 320
  • [7] Detection of ERBB2 Amplification by Next-Generation Sequencing Predicts HER2 Expression in Colorectal Carcinoma
    Cenaj, Odise
    Ligon, Azra H.
    Hornick, Jason L.
    Sholl, Lynette M.
    AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2019, 152 (01) : 97 - 108
  • [8] Detection of ERBB2 (HER2) amplification by next-generation sequencing (NGS) in patients (pts) with gastrointestinal (GI) cancer
    Qi, Y.
    Huang, L.
    Jin, Y.
    Ruan, F.
    He, H.
    ANNALS OF ONCOLOGY, 2023, 34 : S261 - S261
  • [9] Clinical Utility of HER2/ERBB2 Copy Number Analysis by Next Generation Sequencing in Metastatic Breast Cancer
    Xia, Daniel
    Kuo, Frank
    Dillon, Deborah
    MODERN PATHOLOGY, 2018, 31 : 113 - 113
  • [10] Clinical Utility of HER2/ERBB2 Copy Number Analysis by Next Generation Sequencing in Metastatic Breast Cancer
    Xia, Daniel
    Kuo, Frank
    Dillon, Deborah
    LABORATORY INVESTIGATION, 2018, 98 : 113 - 113
12345